• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Bicycle Health, Wellpath to Provide Opioid Use Disorder Treatment to Federal Bureau of Prisons

by Fred Pennic 02/23/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Bicycle Health, Wellpath to Provide Opioid Use Disorder Treatment to Federal Bureau of Prisons

What You Should Know:

– Bicycle Health, a telehealth provider of integrated medical and behavioral health treatment for opioid use disorder (OUD) is teaming up with Wellpath, the premier provider of localized, compassionate care to vulnerable patients in challenging clinical environments, and the Federal Bureau of Prisons (FBOP).

– The collaboration will enable patients to access Bicycle Health’s evidence-based, life-saving clinical care model delivering virtual Medication for Opioid Use Disorder (MOUD) services to individuals living in the FBOP’s Residential Reentry Centers (RRC).

Opioid Use Disorder Treatment to Federal Bureau of Prisons

The collaboration will enable patients to access Bicycle Health’s evidence-based, life-saving clinical care model delivering virtual Medication for Opioid Use Disorder (MOUD) services to individuals living in the FBOP’s Residential Reentry Centers (RRC). Medications like buprenorphine – an FDA-approved medication that limits painful opioid withdrawal symptoms, helps prevent overdose, and supports long-term recovery – have been widely successful at curbing opioid use. The Substance Abuse and Mental Health Services Administration has found that MOUD treatment regimens are significantly underutilized in criminal justice settings. The primary goal of this collaboration is to improve availability and clinically appropriate utilization of MOUD among this underserved patient population.

Bicycle Health’s virtual treatment model, which has shown patient retention rates that are appreciably higher and no-show rates that are significantly lower than in-person averages, will deliver life-saving clinical and behavioral care to a population in need. The collaboration between Bicycle Health and Wellpath will provide improved access to MOUD in RRCs across 42 states, with plans to expand. Bicycle Health and Wellpath plan to grow the service to meet the recovery needs of formerly incarcerated patients – to improve their health, the overall health of the community, and reduce recidivism.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Behavioral Health, Bicycle Health, FDA, medication, Mental Health, model, patient population, Premier, Substance Abuse

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Knowledge Hub

 How Top Health Plans Use AI to Save Money and Work Smarter How Top Health Plans Use AI to Save Money and Work Smarter

 How to Build Hybrid Care Models Around Remote Patient Monitoring How to Build Hybrid Care Models Around Remote Patient Monitoring

Trending

Olive Secures $400M At A $4B Valuation to Support New Instant Claim Payment Solution

Olive Shutters Business After Sale to Waystar and Humata Health

Clinician Shortage Worsens Primary Care Crisis, Experts Reveal

Clinician Shortage Worsens Primary Care Crisis, Experts Reveal

FDA Grants Clearance for UltraSight's AI Cardiac Ultrasound

Israel Defense Forces to Utilize UltraSight’s PoCUS Devices in Combat

The Future of Biomarker-Based Therapy for Mental Disorder Care

The Future of Biomarker-Based Therapy for Mental Disorder Care

HLTH23: 6 Digital Health Executives Share Key Takeaways

6 Digital Health Executives Share Key Takeaways from HLTH23

HIMSS Appoints New Chief Financial Officer & General Counsel

HIMSS Appoints New Chief Financial Officer & General Counsel

GoodRx Now Offers Access to $35 Insulin to All Americans

GoodRx Now Offers Access to $35 Insulin to All Americans

Ozempic: From Diabetes Management to Potential Weight Loss Miracle

Ozempic: From Diabetes Management to Potential Weight Loss Miracle

Health M&A: Financial Distress Driving Q3 Healthcare Deals

Health M&A: Financial Distress Driving Q3 Healthcare Deals

GE HealthCare Inks $44M Contract with BARDA to Develop AI-Driven Ultrasound Tech

GE HealthCare Inks $44M Contract with BARDA to Develop AI-Driven Ultrasound Tech

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |